Imagine a world where woolly mammoths roam the tundra once more—not in a prehistoric dream but as a living, breathing reality. This isn’t science fiction; it’s cutting-edge science happening ...

A startup company is trying to raise money to bring back the woolly mammoth. Colossal Biosciences Inc. uses DNA and genomics in hopes of re-introducing extinct animals to the modern-day world.

Instead of dinosaurs, Colossal has set its sights on more recently lost species including the dodo, the thylacine — also known as the Tasmanian tiger– and the woolly mammoth. The last ...

She came out like a wooly mammoth and Dolly’s the best mum; a real pro. A better mummy you wouldn’t find.” To stay up to date with all the breaking news from major shows throughout 2025 ...

It was one former Husky point guard greeting another as Plum’s jersey joined his and others in the Alaska Airlines Arena rafters. Only six Washington athletes have had their number retired in ...

Among its first rewilding goals: bringing back the woolly mammoth. The last, isolated mammoth populations died out 4,000 years ago, with their extinction blamed on hunting by humans and climate ...

Ben Lamm’s start-up, Colossal Biosciences, has billed itself as the world’s first ‘de-extinction’ company - Colossal Science ...

Woolly mammoths went extinct around 4,000 years ago, but scientists claim America will soon see the prehistoric animal in 2028. Colossal Biosciences, a Texas-based biotechnology and genetic ...

Colossal has also altered the DNA sequence in chicken primordial germ cells (PGCs), injected them into embryos, and successfully hatched chimeric chicks. Their offspring will be surrogates for dodos.

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Digital rendering of the long-extinct woolly mammoth. Courtesy Colossal Biosciences The woolly mammoth could be brought back from extinction in just three years’ time—that is, if everything ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.